Clinical Trial Update: No Resistance After Long Term Treatment SERETIDE [Phase 4]

View source ↗

Summary

A Phase 4 trial of SERETIDE for asthma has been withdrawn. The update notes no resistance after long-term treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Seretide (fluticasone propionate/salmeterol)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 4 | Status: WITHDRAWN